Korean J Gastroenterol.  1998 Sep;32(3):320-331.

Gastrointestinal Stromal Tumor in Stomach : A Clinicopathologic and Immunohistochemical Study

Abstract

BACKGROUND AND AIMS: The origin and chnical behavior of gastrointestinal stromal tumors (GIST) have been a source of recent speculation and controversy. This study was performed to determine the classification and prognostic factors of GIST.
METHODS
The clinicopathologic and immunohistochemical features for the presence of smooth muscle actin (SMA) and S-100 protein (S-100) in the 29 cases with GIST were reviewed.
RESULTS
The ratio of male to female among 29 cases was 20:9 and the median age was 59 (range, 38-73). The operations were performed in the 27 cases (2 cases, wedge resection; 6 cases, partial gastrectomy; 12 cases, total gastrectomy; and 1 case, biopsy). In immunohistochemical study using the antibodies of SMA and S-100, 9 cases showed the immunoreactivity to antibody of SMA. Two cases showed immunoreactivity to antibodies of both SMA and S-100, but 13 cases did not show the immunoreactivity to either antibodies. The positively stained group to the antibody of SMA had the tendency of consisting of spindle shaped cells and low mitosis numbers. The overall 5 year survival rate was 50%. Tumor size, presence of lymph node metastasis, distant metastasis, and degree of nuclear atpypism affected on the survival rate.
CONCLUSIONS
Tumor size (> 10 cm vs 10 cm), presence of lymph node metastasis, distant metastasis and nuclear atypism could be prognostic factors. Local excision with adequate surgical margins seems to show similar outcome compared with conventional gastric resection. The results of immunohistochemical study showed the possibility of diverse cellular origin of GIST in the stomach.

Keyword

Gastrointestinal stromal tumor (GIST); Stomach; Immunohistochemistry; Prognosis

MeSH Terms

Actins
Antibodies
Classification
Female
Gastrectomy
Gastrointestinal Stromal Tumors*
Humans
Immunohistochemistry
Lymph Nodes
Male
Mitosis
Muscle, Smooth
Neoplasm Metastasis
Prognosis
S100 Proteins
Stomach*
Survival Rate
Actins
Antibodies
S100 Proteins
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr